Status:
COMPLETED
Phase 1 BA Study, Single Center With Healthy Volunteers
Lead Sponsor:
Abbott
Conditions:
Healthy
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
Single dose in healthy volunteers to assess bioavailability (amount of study drug in the system) between different formulations of ABT-874.
Eligibility Criteria
Inclusion
- Subjects must be healthy
Exclusion
- Subjects who are not healthy, enrolled in another study, or who have received ABT-874 previously.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT00870948
Start Date
January 1 2009
Last Update
November 8 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Site Reference ID/Investigator # 16001
Evansville, Indiana, United States, 47710